Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways

Toxicology and Applied Pharmacology
Lin LiPo Sing Leung

Abstract

Pancreatic cancer is difficult to detect early and responds poorly to chemotherapy. A breakthrough in the development of new therapeutic agents is urgently needed. Eriocalyxin B (EriB), isolated from the Isodon eriocalyx plant, is an ent-kaurane diterpenoid with promise as a broad-spectrum anti-cancer agent. The anti-leukemic activity of EriB, including the underlying mechanisms involved, has been particularly well documented. In this study, we demonstrated for the first time EriB's potent cytotoxicity against four pancreatic adenocarcinoma cell lines, namely PANC-1, SW1990, CAPAN-1, and CAPAN-2. The effects were comparable to that of the chemotherapeutic camptothecin (CAM), but with much lower toxicity against normal human liver WRL68 cells. EriB's cytoxicity against CAPAN-2 cells was found to involve caspase-dependent apoptosis and cell cycle arrest at the G2/M phase. Moreover, the p53 pathway was found to be activated by EriB in these cells. Furthermore, in vivo studies showed that EriB inhibited the growth of human pancreatic tumor xenografts in BALB/c nude mice without significant secondary adverse effects. These results suggest that EriB should be considered a candidate for pancreatic cancer treatment.

References

Apr 29, 1998·Annual Review of Physiology·K L King, J A Cidlowski
Jun 13, 1998·Anti-cancer Drugs·M S AaproS Hatty
Feb 5, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J U LeeM Imamura
Sep 29, 2001·Phytochemistry·B Li, X Tian
Nov 16, 2001·Biochemical Society Transactions·M Schuler, D R Green
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Sep 25, 2002·Drugs·Hulya Ulukan, Peter W Swaan
Nov 27, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Tito Fojo
Jun 20, 2003·Cell Proliferation·Katrien VermeulenZwi N Berneman
Aug 5, 2003·BioFactors·Martine Torres, Henry Jay Forman
Dec 12, 2003·Clinical Lung Cancer·Adrian M Senderowicz
Mar 9, 2004·Biochemical and Biophysical Research Communications·Atsuya HabiroYutaka Kohgo
Aug 24, 2004·Annals of Hematology·Jia-Jun LiuHui-Ling Lu
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael McCullochJohn M Colford
Sep 28, 2006·Natural Product Reports·Han-Dong SunQuan-Bin Han
Jan 24, 2007·Physiological Reviews·Guido KroemerCatherine Brenner
May 15, 2007·Oncogene·A S DhillonW Kolch
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Apr 4, 2008·Phytotherapy Research : PTR·Sin Ting LauPo Sing Leung
Aug 30, 2008·Molecular Cancer Therapeutics·Jessica R KirshnerJohn Bertin
Sep 9, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Jiahao LiuChang-seng Liang
Nov 5, 2008·Cancer Biology & Therapy·Jie Wang, Jing Yi
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
Apr 23, 2009·Journal of Cellular and Molecular Medicine·Simone Fulda
Nov 19, 2009·Journal of Agricultural and Food Chemistry·Jaiprakash R PatilBhimanagouda S Patil
Jan 27, 2010·Nature Reviews. Clinical Oncology·Anastasios Stathis, Malcolm J Moore
Jan 30, 2010·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Chien-An ChenYu-Jen Chen
Feb 6, 2010·World Journal of Gastroenterology : WJG·Soley BayraktarCaio Max Rocha-Lima
Feb 26, 2010·International Journal of Cell Biology·Simone FuldaAfshin Samali
Mar 4, 2010·The AAPS Journal·Jing LiJessie L-S Au
Apr 8, 2010·Current Drug Targets·David M LucasA Douglas Kinghorn
May 5, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Grace G L YueClara B S Lau
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Sep 2, 2010·Journal of Natural Products·Liva HarinantenainaDavid G I Kingston
Sep 10, 2010·American Journal of Reproductive Immunology : AJRI·Aliza L LeizerGil Mor
Oct 29, 2010·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Seema GuptaMansoor M Ahmed
Feb 8, 2011·The International Journal of Biochemistry & Cell Biology·Chun-yang LiJin-ku Bao
May 18, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xiao-Peng ZhangWei Wang

❮ Previous
Next ❯

Citations

May 31, 2014·The International Journal of Biochemistry & Cell Biology·Lin Li, Po Sing Leung
Apr 21, 2018·Molecular Omics·Xunian ZhouStephen Kwok-Wing Tsui
Apr 22, 2020·Natural Products and Bioprospecting·Rong-Fang MuWen-Yong Xiong
Apr 4, 2017·Phytotherapy Research : PTR·Muhammad Torequl Islam
Feb 26, 2019·Journal of Cancer Research and Clinical Oncology·Ming-Yao MengZong-Liu Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.